Madison, Wis. – Stratatech Corp. was awarded a federal Phase II SBIR grant of $922,000 from the National Institute of General Medical Sciences to further develop its engineered human skin products.
Established in 2000, Stratatech is based in Madison and employs 18 people, according to the 2005 edition of the Greater Madison Wisconsin Area Directory of High-Tech Companies. Its products are based on a source of pathogen-free human skin cells that are able to multiply indefinitely, a technology first identified at UW-Madison.